Close

BIO Board of Directors

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors.  The Full BIO Board of Directors is comprised of all the directors sitting on the Section Governing Boards, as described below. 

In addition, there is a Board Executive Committee that consists of the seven Elected Officers of the Organization, the immediate Past Chair of the Organization, the Vice Chairs of each Section's Governing Board, and At-Large Directors selected from the Full Board.

There are four Section Governing Boards organized by industrial sector and policy interest.  They are: (1) the Emerging Companies Section (ECS) Governing Board, (2) the Food & Agriculture (F&A) Section Governing Board, (3) the Health Section Governing Board, and (4) the Industrial & Environmental (I&E) Section Governing Board.  BIO’s four Section Governing Boards are comprised of thought leaders who bring their expertise to bear on major issues affecting their specific area of the biotechnology industry.

From time to time, each Section Governing Board may consider candidates to fill vacancies in accordance with BIO’s Bylaws and their own processes and criteria.  In general, BIO Board candidates should be the CEO or Chairman of the Board of a research and development (R&D) focused biotechnology company, but certain Governing Boards have alternative criteria, especially for larger companies.  To be considered for a BIO Board seat, a candidate typically has this type of affiliation with a BIO member company.  If your organization is not a BIO member, click here to learn more about membership.

BECOME A BIO MEMBER

BIO is committed to fostering workforce development, diversity, and inclusion (WDDI) at BIO and across the biotechnology industry.  To that end, candidates should affirmatively support BIO’s WDDI Principles, and pledge to do her or his part to foster diversity and inclusion among employees, customers, and patients.  BIO’s WDDI Principles can be found at: https://www.bio.org/diversity

If you are interested in nominating yourself or another person to be a candidate and potentially fill a vacancy on the BIO Board, please inquire here to learn more about the BIO Board nomination process:

Inquire about BIO Board Nominations

If you have any questions about the BIO Board of Directors, please contact Peter McHugh at pmchugh@bio.org.

For reference, a diagram of the Board and Committee structure is presented below.

Board and Committee structure

 

Executive Committee

Executive Committee

John Maraganore, PhD Chair
Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
Ron Cohen, MD Immediate Past Chair
CEO, Acorda Therapeutics, Inc.
Bradford A. Zakes, MBA Treasurer
Chief Executive Officer, Cerevast Therapeutics, Inc
Julie L. Gerberding, MD, MPH Secretary
Executive Vice President, Communications, Global Policy, and Population Health &, Merck
Jeremy M. Levin, BChir, DPhil, MB Health Section Vice Chair
Chairman & CEO, Ovid Therapeutics Inc.
Katrine Bosley ECS Chair
Chief Executive Officer, Editas Medicine
Ted W. Love, MD ECS Vice Chair
Chief Executive Officer, Global Blood Therapeutics
Philip W. Miller Food & Ag Section Chair
Sr. Vice President, Agricultural Global Government Relations, Regulatory Policy, Bayer CropScience, Inc.
Ronald L. Stotish Food & Ag Section Vice Chair
Chief Executive Officer, AquaBounty Technologies, Inc.
Alan Shaw, PhD I&E Section Chair
President and Chief Executive Officer, Calysta
Vincent Sewalt, PhD I&E Section Vice Chair
Senior Director, Product Stewardship & Regulatory, Dupont Corporation
Bill Anderson
CEO & Head of North American Commercial Operations, Genentech, A Member of the Roche Group
Stuart A. Arbuckle
Executive Vice President and Chief Commercial Office, Vertex Pharmaceuticals Incorporated
Douglas A. Doerfler
President & CEO, MaxCyte, Inc
Paul J. Hastings
President & CEO, Nkarta Inc.
Rachel K. King
Founder & CEO, GlycoMimetics, Inc.
Joshua J. Ofman, MD, MS
Senior Vice President, Global Value, Access and Policy, Amgen Inc.
Richard Pops
Chairman & CEO, Alkermes, Inc.
Christi L. Shaw, MBA
SVP & President of Lilly Bio-Medicines, Eli Lilly and Company

Section Governing Boards

Emerging Companies Section Governing Board

Katrine Bosley Chair
Chief Executive Officer, Editas Medicine
Ted W. Love, MD Vice Chair
Chief Executive Officer, Global Blood Therapeutics
Martin Babler
Chief Executive Officer, Principia Biopharma
Laura A. Berezin
Partner, Cooley LLP
Abbie Celniker, PhD
Partner, Third Rock Ventures, LLC
Jeffrey L. Cleland, PhD
Executive Chair & President, Orpheris, Inc.
Ron Cohen, MD
CEO, Acorda Therapeutics, Inc.
John F. Crowley, JD, MBA
Chairman & CEO, Amicus Therapeutics, Inc.
Bassil I. Dahiyat, PhD
President & CEO, Xencor, Inc
Douglas A. Doerfler
President & CEO, MaxCyte, Inc
Mark Drozdowski
Partner - Pharmaceuticals National Audit Leader, KPMG LLP
Cedric Francois, PhD
CEO, Apellis Pharmaceuticals, Inc
Kevin C. Gorman, PhD
President & CEO, Neurocrine Biosciences, Inc
Justin Gover
Chief Executive Officer, GW Pharmaceuticals Plc
Paul J. Hastings
President & CEO, Nkarta Inc.
Russell H. Herndon
President & CEO, Hydra Biosciences, Inc
Jeff B. Kindler
Chief Executive Officer, Centrexion Therapeutics
Rachel K. King
Founder & CEO, GlycoMimetics, Inc.
Scott Koenig, MD, PhD
President & CEO, MacroGenics, Inc
Nick Leschly
President & CEO, bluebird bio
Jeremy M. Levin, BChir, DPhil, MB
Chairman & CEO, Ovid Therapeutics Inc.
Ted W. Love, MD
Chief Executive Officer, Global Blood Therapeutics
Sandy Macrae, PhD
President & CEO, Sangamo Therapeutics, Inc.
David Main
Chief Executive Officer, Aquinox Pharmaceuticals, Inc.
John Maraganore, PhD
Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
Jeffrey D. Marrazzo
Co-Founder & CEO, Spark Therapeutics
Sharon Mates, PhD
Chairman & CEO, Intra-Cellular Therapies, Inc.
Steven J. Mento, PhD
President & CEO, Co-Founder, Conatus Pharmaceuticals, Inc
Kenneth I. Moch
President & CEO, Cognition Therapeutics
Bob J. More
Managing Director, Alta Partners
Lonnie Moulder
Chief Executive Officer, Tesaro, Inc.
Michael Narachi, MBA, MS
Chief Executive Officer, CODA Biotherapeutics
Amir Nashat
Managing Partner, Polaris Ventures
William J. Newell, JD
Chief Executive Officer, Sutro Biopharma, Inc
Julia Owens, PhD
President & CEO, Millendo Therapeutics Inc.
Carlos V. Paya, MD, PhD
Chief Executive Officer, Immune Design Corporation
Adelene Q. Perkins, MBA
Chief Executive Officer, Infinity Pharmaceuticals, Inc.
Anna Protopapas, MBA
President & CEO, Mersana Therapeutics, Inc.
Mark Pruzanski, MD
Founder, President & CEO, Intercept Pharmaceuticals, Inc.
Michael G. Raab
Chief Executive Officer, Ardelyx Inc.
George A. Scangos, PhD
Chief Executive Officer, VIR Biotechnology, Inc.
Nancy Simonian, MD
Chief Executive Officer, Syros Pharmaceuticals
Erika Smith, MBA
Chief Executive Officer, ReNetX Bio
Gil Van Bokkelen, PhD
Chairman & CEO, Athersys, Inc.
Timothy P. Walbert
Chairman, President & CEO, Horizon Pharma, plc
Sue Washer, MBA
President & CEO, Applied Genetic Technologies Corporation (AGTC)
Thomas G. Wiggans, MBA
Founder & CEO, Dermira, Inc.
Robert J. Wills, PhD
Executive Chairman, GTx, Inc
Bradford A. Zakes, MBA
Chief Executive Officer, Cerevast Therapeutics, Inc

Food & Ag Section Governing Board

Philip W. Miller Chair
Sr. Vice President, Agricultural Global Government Relations, Regulatory Policy, Bayer CropScience, Inc.
Ronald L. Stotish Vice Chair
Chief Executive Officer, AquaBounty Technologies, Inc.
Jerry Flint
Vice President, Global Initiatives and Sustainability, Corteva Agriscience
Scott Holmstrom
Senior Director, Global Product Development, Elanco
Sarah Hull
Global Head Business Sustainability Seeds/Head Business Sustainability N.A., Syngenta
Tammy Lee
President & CEO, Recombinetics, Inc
Dan Meagher
President & CEO, Agrivida, Inc.
Adam Monroe
President, Americas, Novozymes
Eddie J. Sullivan, PhD
President & CEO, SAB Biotherapeutics
Karsten Temme, PhD
CEO & Co-Founder, Pivot Bio, Inc.

Health Section Governing Board

John Maraganore, PhD Chair
Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
Jeremy M. Levin, BChir, DPhil, MB Vice Chair
Chairman & CEO, Ovid Therapeutics Inc.
Ron Cohen, MD Immediate Past Chair
CEO, Acorda Therapeutics, Inc.
Paul J. Hastings Secretary
President & CEO, Nkarta Inc.
Gregg H. Alton, Esq
Executive Vice President, Corporate and Medical Affairs, Gilead Sciences, Inc.
Bill Anderson
CEO & Head of North American Commercial Operations, Genentech, A Member of the Roche Group
Stuart A. Arbuckle
Executive Vice President and Chief Commercial Office, Vertex Pharmaceuticals Incorporated
Martin Babler
Chief Executive Officer, Principia Biopharma
Jean-Jacques Bienaime
President & CEO, BioMarin Pharmaceutical, Inc.
Katrine Bosley
Chief Executive Officer, Editas Medicine
Carsten Brunn, PhD
Head of Pharmaceuticals, Americas Region, Bayer Corporation
Bill Campbell
Executive Vice President and Chief Commercial Officer, CSL Behring
Fabrice Chouraqui, PhD
President, Novartis Pharmaceuticals Corporation
Terrie Curran
President, Inflammation and Immunology, Celgene Corporation
Douglas A. Doerfler
President & CEO, MaxCyte, Inc
Mark Enyedy
President & CEO, ImmunoGen, Inc.
William Fitzsimmons, MS, PharmD
Divisional EVP for Global Regulatory Affairs & Global Clinical &Research Quality, Astellas Pharma US, Inc.
Barry Flannelly, MBA, PharmD
Executive Vice President & General Manager US, Incyte Corporation
Julie L. Gerberding, MD, MPH
Executive Vice President, Communications, Global Policy, and Population Health &, Merck
Christopher P. Healey
VP, Public Affairs, Grifols
Russell H. Herndon
President & CEO, Hydra Biosciences, Inc
Rachel K. King
Founder & CEO, GlycoMimetics, Inc.
Scott Koenig, MD, PhD
President & CEO, MacroGenics, Inc
Joseph LaRosa, Esq
Senior Vice President, General Counsel and Secretary, Regeneron Pharmaceuticals, Inc.
John Lepore, MD
SVP, R&D Pipeline, GlaxoSmithKline
Nick Leschly
President & CEO, bluebird bio
Elizabeth Lewis
Chief Counsel, Global Oncology Business Unit, Patient Advocacy, Takeda Oncology
Ted W. Love, MD
Chief Executive Officer, Global Blood Therapeutics
Paige Mahaney, PhD
Global Head of Biotherapeutics Discovery Research and Discovery Research Site Head, Boehringer Ingelheim
Jeffrey D. Marrazzo
Co-Founder & CEO, Spark Therapeutics
Kiran Mazumdar-Shaw
Chairperson & Managing Director, Biocon Limited
Paul McKenzie, PhD
EVP, Pharmaceutical Operations & Technology, Biogen
Clive A. Meanwell, MD, PhD
Founder, Chairman & CEO, The Medicines Company
Steven J. Mento, PhD
President & CEO, Co-Founder, Conatus Pharmaceuticals, Inc
Kenneth I. Moch
President & CEO, Cognition Therapeutics
Michael M. Morrissey, PhD
President & CEO, Exelixis, Inc.
Michael Narachi, MBA, MS
Chief Executive Officer, CODA Biotherapeutics
William J. Newell, JD
Chief Executive Officer, Sutro Biopharma, Inc
David Nicholson, PhD
EVP & Chief R&D Officer, Allergan
Joshua J. Ofman, MD, MS
Senior Vice President, Global Value, Access and Policy, Amgen Inc.
Carlos V. Paya, MD, PhD
Chief Executive Officer, Immune Design Corporation
Adelene Q. Perkins, MBA
Chief Executive Officer, Infinity Pharmaceuticals, Inc.
Anne Phillips, MD
SVP, Clinical, Medical & Regulatory Affairs, Novo Nordisk
Richard Pops
Chairman & CEO, Alkermes, Inc.
Shaji Procida
President & COO, Eisai, Inc
Mark Pruzanski, MD
Founder, President & CEO, Intercept Pharmaceuticals, Inc.
Howard W. Robin
President & CEO, Nektar Therapeutics, Inc.
Michael Ryan, PharmD
SVP, Worldwide Value, Access, Policy & Health Economics & Outcomes Research, Bristol-Myers Squibb Company
Christi L. Shaw, MBA
SVP & President of Lilly Bio-Medicines, Eli Lilly and Company
Bill Sibold, MBA
Executive Vice President, Genzyme Corporation, A Sanofi Company
Nancy Simonian, MD
Chief Executive Officer, Syros Pharmaceuticals
David M. Stack
President & CEO, Pacira Pharmaceuticals, Inc.
Perry J. Sternberg
EVP & Head of US Commercial, Shire
James Sullivan, PhD
Vice President, Pharmaceutical Discovery, AbbVie Inc.
Jennifer Taubert
Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
Helen Torley, MRCP
President & CEO, Halozyme Therapeutics, Inc.
Mark Trudeau
President & CEO, Mallinckrodt Pharmaceuticals
Gil Van Bokkelen, PhD
Chairman & CEO, Athersys, Inc.
Charl Van Zyl
Chief Operating Officer, UCB SA
Timothy P. Walbert
Chairman, President & CEO, Horizon Pharma, plc
H. Thomas Watkins
Chair Emeritus, BIO, Biotechnology Innovation Organization
Rick E. Winningham
Chief Executive Officer, Theravance Biopharma US, Inc.
John Young
Group President of Pfizer Innovative Health, Pfizer Inc.
Gary Zieziula
President & Managing Director, North America, EMD Serono, Inc.

Industrial & Environmental Section Governing Board

Alan Shaw, PhD Chair
President and Chief Executive Officer, Calysta
Hugh C. Welsh, JD Vice Chair
President, DSM North America
Doug Berven
Vice President, Corporate Affairs, Poet, LLC
Pat R. Gruber, MBA, PhD
Chief Executive Officer, Gevo, Inc
Jennifer Holmgren, MBA, PhD
Chief Executive Officer, LanzaTech
David Kettner
Vice President of Legal Affairs, Virent, Inc
John G. Melo
Chief Executive Officer, Amyris, Inc.
Anna Rath
President & CEO, Vestaron Corporation
Christophe Schilling, PhD
Chief Executive Officer, Genomatica, Inc
Chris Standlee
Vice President, ICM, Inc
Brian Thome
Chief Executive Officer, Edeniq Inc.
Oliver Walker
Chief Executive Officer, Evolva SA
Bob F. Walsh
Senior Vice President, Intrexon Corporation
Roger Wyse, PhD
Managing Director, Spruce Capital Partners
Jill Zullo, PhD
Vice President, Bioindustrials NA, Cargill, Inc